Skip to content
Advertisement

Former Turing Pharmaceuticals CEO Martin Shkreli, center, leaves court with his lawyer Benjamin Brafman, left, Wednesday, Feb. 3, 2016, in New York. Shkreli, who has become the poster child of pharmaceutical-industry greed after hiking the price of an anti-infection drug by more than 5,000 percent, is scheduled to appear at a congressional hearing on Thursday. (AP Photo/Seth Wenig)
Photo by: Seth Wenig
Former Turing Pharmaceuticals CEO Martin Shkreli, center, leaves court with his lawyer Benjamin Brafman, left, Wednesday, Feb. 3, 2016, in New York. Shkreli, who has become the poster child of pharmaceutical-industry greed after hiking the price of an anti-infection drug by more than 5,000 percent, is scheduled to appear at a congressional hearing on Thursday. (AP Photo/Seth Wenig)

Featured Photo Galleries